ELQ-598

Description: ELQ-598, a prodrug, is converted to the active drug ELQ-596 upon oral administration. It demonstrates potent parasitic growth inhibition capabilities (IC50 = 37 nM) and shows low toxicity towards human cells (IC50 = 19 µM). ELQ-598 can be used for research into babesiosis [1]. Target: Parasite. Smiles: O(COC(OCC)=O)C=1C2=C(N=C(C)C1C3=CC=C(C=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C(OC)C(Cl)=C2